IonQ is trading 5.04% lower at $32.98, with investors focused on potential dilution from its proposed Elisity acquisition.

  • Announced October 12, the all-stock deal is valued at up to $1.3 billion, including up to $150 million in performance-based earnouts.
  • Shares closed at $34.73 on October 13, down 4.25%, and at $36.27 on October 12, down 9.07%.
  • October 14 coverage continued to identify dilution concerns as pressure on shares; the broader market was softer, with supplied index moves smaller than IonQ’s decline.